title: Micafungin at a standard dosage of 100 mg/day achieves adequate plasma exposure in critically ill patients with severe burn injuries.
authors.affiliation: Burn Unit, Intensive Care Medicine Service, La Paz University Hospital, IdiPAZ Institute for Health Research, Orthopaedics Surgery Hospital, Paseo de la Castellana 261, 4th Floor, 28046, Madrid, Spain.
authors.forename: M J
authors.initials: MJ
authors.lastname: Asensio
authors.forename: M
authors.initials: M
authors.lastname: Sánchez
authors.forename: B
authors.initials: B
authors.lastname: Galván
authors.forename: E
authors.initials: E
authors.lastname: Herrero
authors.forename: L
authors.initials: L
authors.lastname: Cachafeiro
authors.forename: A
authors.initials: A
authors.lastname: Agrifoglio
authors.forename: E
authors.initials: E
authors.lastname: Perales
authors.forename: S
authors.initials: S
authors.lastname: Luque
authors.forename: A
authors.initials: A
authors.lastname: García-de-Lorenzo
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000935:Antifungal Agents / Q000008:administration & dosage* / Q000097:blood / Q000627:therapeutic use; D002056:Burns / Q000150:complications / Q000188:drug therapy*; D058365:Candidiasis, Invasive / Q000188:drug therapy*; D003422:Critical Care; D016638:Critical Illness; D054714:Echinocandins / Q000008:administration & dosage* / Q000097:blood / Q000627:therapeutic use; D005260:Female; D006801:Humans; D055666:Lipopeptides / Q000008:administration & dosage* / Q000097:blood / Q000627:therapeutic use; D008297:Male; D000077551:Micafungin; D008875:Middle Aged; D014946:Wound Infection / Q000188:drug therapy*; D055815:Young Adult
chemical_list: D000935:Antifungal Agents; D054714:Echinocandins; D055666:Lipopeptides; D000077551:Micafungin